key: cord-0714443-lyo53peo
authors: Tutuncu, Emin Ediz; Ozgur, Didem; Karamese, Murat
title: Saliva samples for detection of SARS‐CoV‐2 in mildly symptomatic and asymptomatic patients
date: 2021-02-09
journal: J Med Virol
DOI: 10.1002/jmv.26821
sha: 32f7ecfc3b3f8a64ceca305ce9056e5070a3797f
doc_id: 714443
cord_uid: lyo53peo

BACKGROUND: The ongoing coronavirus disease 2019 (Covid‐19) pandemic has been rapidly spreading throughout the world with confirmed case numbers already exceeding 75 million. Although nasopharyngeal swabs are the most commonly utilized samples for based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) RNA detection, collecting these specimens requires healthcare workers and necessitates the use of personal protective equipment as it presents a nosocomial transmission risk. We aimed to assess the diagnostic value of saliva samples in mildly symptomatic and asymptomatic patients with confirmed Covid‐19. METHODS: We performed a cohort study to validate the use of saliva for SARS‐CoV‐2 detection in mildly symptomatic and asymptomatic patients with a confirmed diagnosis of Covid‐19. Saliva samples of the patients were analyzed by reverse‐transcriptase polymerase chain reaction (RT‐PCR). RESULTS: In May 2020, 28 asymptomatic and 25 mildly symptomatic patients were enrolled in the study. The median age was 37 years (range 4–70). None of the patients had a fever on presentation. Among 53 patients with SARS‐CoV‐2 detected in the nasopharyngeal sample, the real‐time RT‐PCR was positive in the saliva specimens in 48 (90.56%) patients. The mean cycle threshold (CT) values for nasopharyngeal and saliva specimens (27.80 ± 3.44 and 30.64 ± 2.83, respectively) were significantly correlated between the two sample types (p = .016). The mean CT values of nasopharyngeal and saliva samples in mildly symptomatic and asymptomatic patients (27.18 ± 3.53 and 30.24 ± 3.29 vs. 28.36 ± 3.31 and 30.98 ± 2.39, respectively) were not significantly different (p = .236 and p = .733, respectively). CONCLUSIONS: Saliva specimens can be considered as a reliable and less resource‐intensive alternative to nasopharyngeal specimens for screening asymptomatic SARS‐CoV‐2 infections.

A cluster of patients with pneumonia of unknown cause was reported in Wuhan, China in December 2019. Shortly after, a new coronavirus, currently known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the etiologic agent. 1, 2 The infection has spread rapidly worldwide due to the high transmissibility of SARS-CoV-2. 3 On March 11, 2020, the WHO declared coronavirus disease 2019 (Covid-19) a global pandemic. As of the end of June 2020, more than 10 million confirmed cases of have been reported worldwide with over 500,000 deaths. 4 High attack rate and transmission from even asymptomatic carriers to others require timely diagnosis of suspected cases and strict infection control measures and public health interventions to contain the outbreak. 3, 5 Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) based SARS-CoV-2 RNA detection in respiratory samples is the gold standard for Covid-19 diagnosis. 6 For initial diagnostic testing of SARS-CoV-2, Centers for Disease Control recommends collecting and testing an upper respiratory specimen. A nasopharyngeal swab and/or an oropharyngeal swab are often recommended for screening or diagnosis of early infection but nasal mid-turbinate or anterior nares samples are also acceptable. 7 On the other hand, it has been demonstrated that saliva has a high concordance rate with nasopharyngeal specimens for RT-PCR detection of respiratory pathogens, including two seasonal human coronaviruses. 8, 9 To date, there are a few studies regarding the possible role of saliva in the detection of SARS-CoV-2 in hospitalized severe Covid- 

Statistical analysis was performed with the Statistical Package for the Social Sciences version 22.0 (SPSS; IBM). The "number," "percentage," "mean," and "SD" were used for the descriptive statistics of the continuous variables. The Pearson correlation analysis was used to evaluate two numerical data (CT values of two different samples).

The independent samples t-test or Mann-Whitney U test were used to compare two independent groups. The Pearson χ 2 or Fisher's exact tests were used to analyze categorical data. The results were evaluated with a confidence interval of 95%, and the level of significance, p, was set at 0.05.

The cohort consisted of 53 patients with confirmed Covid-19 infection, of whom 21 (39.6%) were males. The median age of patients was None of the patients had a fever on presentation. The most common symptom was dry cough in 15 (28.3%) patients, followed by fatigue in 10 (18.9%) and sore throat in eight (15.1%) patients, and two (3.8%) patients presented with anosmia. Twenty-eight patients Table 1 . There were no significant differences between the two groups, except asymptomatic patients were younger than those with mild symptoms (p = .026). respectively. There were no statistically significant differences between the two groups (p = .236 and p = .733, respectively).

We also evaluated the mean CT values for patients with or without evidence of pneumonia on tomography. The mean CT values for nasopharyngeal and saliva specimens in patients with pneumonia were lower than those without pneumonia (26.23 ± 3.56 and 29.15 ± 3.90 vs. 28.12 ± 3.36 and 30.94 ± 2.52, respectively) although the difference was not significant (p = .077 and p = .154, respectively). However, the nasopharyngeal sample's sensitivity is variable, partly due to deficiency in sampling technique and requiring experienced healthcare personnel. Furthermore, the collection of nasopharyngeal specimens causes discomfort to patients due to the procedure's invasiveness. 11 Moreover, nasopharyngeal sampling requires close contact between the patient and the healthcare worker and presents a considerable transmission risk to healthcare workers because it can induce patients to sneeze or cough, generating T A B L E 1 Demographic and laboratory findings of mildly symptomatic and asymptomatic patients aerosols. 12, 13 Therefore, this procedure requires using personal protective equipment including an N95 respirator, eye protection, gloves, and a gown when collecting specimens. 7 As the pandemic is evolving, global shortages of key equipment needed to care for patients such as personal protective equipment and adequate swabs or viral transport medium for sampling procedures becomes a growing problem, especially in resource-limited settings. 14 These challenges are expected to be further exacerbated as the Covid-19 pandemic intensifies in low-income countries. 13 These limitations related to the nasopharyngeal sampling necessitates the validation of new diagnostic approaches.

Saliva sampling is an appealing alternative to nasopharyngeal swabs, as collecting saliva is noninvasive, easy to self-administer, and diminishes the need for personal protective equipment use of healthcare workers. 13 Previous reports indicated that SARS-CoV-2 can be detected The aforementioned studies were largely carried out in hospi- Nasopharyngeal sampling is not an ideal screening procedure to be adopted for massive screening practices. 

A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan. China

A novel coronavirus from patients with pneumonia in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster

Coronavirus disease (COVID-19) situation report

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Centers for Disease Control and Pevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)

Comparison between saliva and nasopharyngeal swab specimens for detection of respiratory viruses by multiplex reverse transcription-PCR

Additional molecular testing of saliva specimens improves the detection of respiratory viruses

Diagnostic testing for severe acute respiratory syndrome-related coronavirus-2: a narrative review

Saliva is a reliable tool to detect SARS-CoV-2

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

Critical supply shortages-the need for ventilators and personal protective equipment during the Covid-19 pandemic

Consistent detection of 2019 novel coronavirus in saliva

Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis. medRxiv

Viral dynamics in mild and severe cases of COVID-19

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients